Neutropenia in the age of genetic testing: Advances and challenges
Authors:
- 8 December 2018
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 94 (3) , 384-393
Abstract
Identification of genetic causes of neutropenia informs precision medicine approaches to medical management and treatment. Accurate diagnosis of genetic neutropenia disorders informs treatment options, enables risk stratification, cancer surveillance, and attention to associated medical complications. The rapidly expanding genetic testing options for the evaluation of neutropenia have led to exciting advances but also new challenges. This review provides a practical guide to germline genetic testing for neutropenia.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (T32 HL007574‐36)
- National Institute of Allergy and Infectious Diseases (R24 AI049393)
- National Institute of Diabetes and Digestive and Kidney Diseases (R24 DK099808)
This publication has 97 references indexed in Scilit:
- The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndromeBlood, 2011
- The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndromeBlood, 2011
- Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndromeBlood, 2011
- HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRIAmerican Journal of Medical Genetics Part A, 2010
- Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: Evidence for phenotype determination by modifying genesPediatric Blood & Cancer, 2010
- Neutropenia in type Ib glycogen storage diseaseCurrent Opinion in Hematology, 2010
- Targeted Next-Generation Sequencing Appoints C16orf57 as Clericuzio-Type Poikiloderma with Neutropenia GeneThe American Journal of Human Genetics, 2010
- Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropeniaBritish Journal of Haematology, 2009
- Shwachman-Diamond Syndrome: A Review of the Clinical Presentation, Molecular Pathogenesis, Diagnosis, and TreatmentHematology/Oncology Clinics of North America, 2009
- A Syndrome with Congenital Neutropenia and Mutations inG6PC3New England Journal of Medicine, 2009